The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | Cornog William L | Director | Buy(P) | 10K | $16.38 | $164K |
| May 15, 2026 | Starr Ephraim | SVP, Gen Counsel & Secretary | Tax withholding(F) | 4K | $16.02 | $58K |
| Apr 28, 2026 | Martin William E. III | President Multiomics | Grant(A) | 18K | $24.24 | $431K |
| Feb 6, 2026 | Nova Tina Susan | Director | Grant(A) | 6K | $27.85 | $158K |
| Feb 5, 2026 | Koffey Quentin | Director | Grant(A) | 6K | — | $0 |
| Feb 5, 2026 | Davis Robyn C | Director | Grant(A) | 6K | — | — |
| Feb 5, 2026 | McLaughlin Erica | Director | Grant(A) | 6K | $27.85 | $158K |
| Feb 5, 2026 | Casal Frank | Director | Grant(A) | 7K | $27.85 | $202K |
| Feb 5, 2026 | Doshi Dipal | Director | Grant(A) | 6K | $27.85 | $158K |
| Feb 5, 2026 | Madaus Martin D | Director | Grant(A) | 6K | — | — |
| Feb 5, 2026 | Cornog William L | Director | Grant(A) | 6K | — | — |
| Nov 24, 2025 | Starr Ephraim | SVP, Gen Counsel & Secretary | Grant(A) | 34K | — | $0 |
| Nov 24, 2025 | Zhou Ginger | SVP and GM, Multiomics | Grant(A) | 13K | — | $0 |
| Nov 24, 2025 | Pirogova Olga | SVP and CHRO | Grant(A) | 16K | — | $0 |
| Nov 24, 2025 | Lin Lawrence Y. | EVP, CFO and Treasurer | Grant(A) | 37K | — | $0 |
| Nov 24, 2025 | Marotta John | President and CEO, Director | Grant(A) | 118K | — | $0 |
| Nov 14, 2025 | Marotta John | President and CEO, Director | Tax withholding(F) | 11K | $29.75 | $327K |
| Nov 14, 2025 | Lin Lawrence Y. | EVP, CFO and Treasurer | Tax withholding(F) | 3K | $29.75 | $90K |
| Nov 14, 2025 | Pirogova Olga | SVP and CHRO | Tax withholding(F) | 2K | $29.75 | $46K |
| Nov 14, 2025 | Zhou Ginger | SVP and GM, Multiomics | Tax withholding(F) | 1K | $29.75 | $33K |
| Sep 10, 2025 | Marotta John | President and CEO, Director | Sell(S) | 316 | $29.41 | $9K |
| Aug 12, 2025 | Zhou Ginger | SVP and GM, Multiomics | Sell(S) | 1K | $28.54 | $31K |
| Aug 12, 2025 | Pirogova Olga | SVP and CHRO | Sell(S) | 1K | $28.54 | $31K |
| Aug 11, 2025 | Lin Lawrence Y. | EVP, CFO and Treasurer | Buy(P) | 3K | $27.96 | $70K |
| Jun 2, 2025 | Marotta John | President and CEO, Director | Buy(P) | 1K | $25.99 | $26K |
| May 30, 2025 | Malus Alan J | Director | Buy(P) | 12K | $26.65 | $320K |
| May 20, 2025 | Cornog William L | Director | Buy(P) | 3K | $27.37 | $75K |
| May 19, 2025 | Cornog William L | Director | Buy(P) | 4K | $26.98 | $112K |
| May 16, 2025 | Cornog William L | Director | Buy(P) | 100 | $26.50 | $3K |
| May 15, 2025 | Starr Ephraim | SVP, Gen Counsel & Secretary | Grant(A) | 38K | $26.71 | $1.0M |
| May 9, 2025 | Lin Lawrence Y. | EVP, CFO and Treasurer | Grant(A) | 4K | $27.49 | $110K |
| May 9, 2025 | Marotta John | President and CEO, Director | Grant(A) | 2K | $27.49 | $49K |
| May 8, 2025 | Lin Lawrence Y. | EVP, CFO and Treasurer | Grant(A) | 2K | $27.67 | $55K |
| May 8, 2025 | Marotta John | President and CEO, Director | Grant(A) | 4K | $27.49 | $100K |
| Feb 11, 2025 | Lin Lawrence Y. | EVP, CFO and Treasurer | Grant(A) | 2K | $46.00 | $101K |
| Feb 7, 2025 | McLaughlin Erica | Director | Grant(A) | 4K | $52.32 | $211K |
| Feb 7, 2025 | Doshi Dipal | Director | Grant(A) | 4K | $52.32 | $211K |
| Feb 7, 2025 | Nova Tina Susan | Director | Grant(A) | 4K | $52.32 | $211K |
| Feb 7, 2025 | Davis Robyn C | Director | Grant(A) | 4K | $52.32 | $211K |
| Feb 7, 2025 | Casal Frank | Director | Grant(A) | 5K | $52.32 | $270K |
| Feb 7, 2025 | Malus Alan J | Director | Grant(A) | 4K | $52.32 | $211K |
| Feb 7, 2025 | Cornog William L | Director | Grant(A) | 4K | — | — |
| Feb 7, 2025 | Madaus Martin D | Director | Grant(A) | 4K | — | — |
| Feb 7, 2025 | Koffey Quentin | Director | Grant(A) | 4K | — | $0 |
| Feb 3, 2025 | Hughes Violetta | VP, Chief Accounting Officer | Sell(S) | 317 | $52.97 | $17K |
| Jan 31, 2025 | Zhou Ginger | SVP and General Manager, Genom | Buy(P) | 417 | $45.88 | $19K |
| Dec 5, 2024 | Lin Lawrence Y. | EVP, CFO and Treasurer | Grant(A) | 23K | $45.00 | $1.0M |
| Dec 5, 2024 | Lin Lawrence Y. | EVP, CFO and Treasurer | Grant(A) | 6K | $45.00 | $260K |
| Dec 4, 2024 | Wang David Dong | SVP & GM, SMS | Disposed to issuer(D) | 140 | $46.65 | $7K |
| Nov 19, 2024 | Madaus Martin D | Director | Buy(P) | 5K | $40.77 | $201K |
| Nov 19, 2024 | Marotta John | President and CEO, Director | Buy(P) | 1K | $40.67 | $51K |
| Nov 19, 2024 | Cueto Herman | EVP, Chief Financial Officer | Sell(S) | 712 | $40.07 | $29K |
| Nov 19, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Sell(S) | 1K | $40.07 | $46K |
| Nov 19, 2024 | Wang David Dong | SVP & GM, SMS | Sell(S) | 348 | $40.07 | $14K |
| Nov 19, 2024 | Zhou Ginger | SVP and General Manager, Genom | Sell(S) | 491 | $40.07 | $20K |
| Nov 19, 2024 | Hughes Violetta | VP, Chief Accounting Officer | Sell(S) | 163 | $40.07 | $7K |
| Nov 19, 2024 | Pirogova Olga | SVP and CHRO | Sell(S) | 548 | $40.07 | $22K |
| Nov 18, 2024 | Cornog William L | Director | Buy(P) | 13K | $39.60 | $495K |
| Nov 18, 2024 | Hirsch Didier | Director | Buy(P) | 1K | $39.50 | $40K |
| Nov 18, 2024 | Marotta John | President and CEO, Director | Buy(P) | 13K | $39.48 | $502K |
| Nov 15, 2024 | Zhou Ginger | SVP and General Manager, Genom | Grant(A) | 9K | $41.51 | $359K |
| Nov 15, 2024 | Wang David Dong | SVP & GM, SMS | Grant(A) | 9K | $41.51 | $359K |
| Nov 15, 2024 | Hughes Violetta | VP, Chief Accounting Officer | Grant(A) | 7K | $41.51 | $287K |
| Nov 15, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Grant(A) | 14K | $41.51 | $575K |
| Nov 15, 2024 | Marotta John | President and CEO, Director | Grant(A) | 84K | $41.51 | $3.5M |
| Nov 15, 2024 | Pirogova Olga | SVP and CHRO | Grant(A) | 10K | $41.51 | $431K |
| Nov 6, 2024 | Cornog William L | Director | Disposed to issuer(D) | 995 | $46.52 | $46K |
| Nov 6, 2024 | Malus Alan J | Director | Disposed to issuer(D) | 995 | $46.52 | $46K |
| Nov 6, 2024 | Koffey Quentin | Director | Grant(A) | 995 | — | $0 |
| Oct 17, 2024 | Cueto Herman | EVP, Chief Financial Officer | Sell(S) | 2K | $43.68 | $70K |
| Sep 9, 2024 | Marotta John | President and CEO, Director | Grant(A) | 3K | $46.15 | $151K |
| Aug 9, 2024 | Zhou Ginger | SVP and General Manager, Genom | Grant(A) | 6K | $55.27 | $350K |
| Aug 9, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Grant(A) | 11K | $55.27 | $600K |
| Aug 9, 2024 | Pirogova Olga | SVP and CHRO | Grant(A) | 6K | $55.27 | $350K |
| Aug 9, 2024 | Wang David Dong | SVP & GM, SMS | Grant(A) | 6K | $55.27 | $350K |
| Aug 9, 2024 | Cueto Herman | EVP, Chief Financial Officer | Grant(A) | 11K | $55.27 | $625K |
| Aug 1, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Disposed to issuer(D) | 1K | $62.05 | $62K |
| Jul 25, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Disposed to issuer(D) | 3K | $60.00 | $180K |
| May 20, 2024 | Hughes Violetta | VP, Chief Accounting Officer | Disposed to issuer(D) | 584 | $51.36 | $30K |
| Apr 1, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Disposed to issuer(D) | 1K | $60.15 | $60K |
| Mar 8, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Disposed to issuer(D) | 4K | $67.50 | $270K |
| Mar 7, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Disposed to issuer(D) | 4K | $65.00 | $260K |
| Mar 7, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Disposed to issuer(D) | 1K | $65.21 | $65K |
| Mar 7, 2024 | Joseph Jason | SVP, General Counsel, Secy. | Disposed to issuer(D) | 4K | $65.20 | $261K |
| Feb 12, 2024 | Nova Tina Susan | Director | Grant(A) | 2K | $65.93 | $163K |
| Feb 12, 2024 | McLaughlin Erica | Director | Grant(A) | 2K | $65.93 | $163K |
| Feb 12, 2024 | Rosenblatt Michael | Director | Grant(A) | 2K | $65.93 | $163K |
| Feb 12, 2024 | Davis Robyn C | Director | Grant(A) | 2K | $65.93 | $163K |
| Feb 12, 2024 | Casal Frank | Director | Grant(A) | 4K | $65.93 | $238K |
| Feb 12, 2024 | Hirsch Didier | Director | Grant(A) | 2K | $65.93 | $163K |
| Feb 12, 2024 | Madaus Martin D | Director | Grant(A) | 2K | $65.93 | $163K |
| Feb 12, 2024 | Bousa Edward Peter | Director | Grant(A) | 2K | $65.93 | $163K |
| Feb 1, 2024 | Vacha Robin | SVP, GM Life Science Products | Grant(A) | 324 | $39.41 | $13K |
| Feb 1, 2024 | Zhou Ginger | SVP and General Manager, Genom | Grant(A) | 448 | $39.41 | $18K |
| Jan 31, 2024 | Vacha Robin | SVP, GM Life Science Products | Grant(A) | 151 | $53.01 | $8K |
| Jan 31, 2024 | Zhou Ginger | SVP and General Manager, Genom | Grant(A) | 64 | $53.01 | $3K |
| Jan 31, 2024 | Hughes Violetta | VP, Chief Accounting Officer | Grant(A) | 311 | $65.20 | $20K |
| Dec 5, 2023 | Vacha Robin | SVP, GM Life Science Products | Disposed to issuer(D) | 5K | $56.60 | $293K |
| Dec 1, 2023 | Wang David Dong | SVP & GM, SMS | Disposed to issuer(D) | 138 | $57.96 | $8K |
| Nov 17, 2023 | Gray David C | Chief Strategy & New Business | Disposed to issuer(D) | 5K | $54.83 | $284K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).